非酒精性脂肪性肝炎诊断的研究进展
Advances in the diagnosis of nonalcoholic steatohepatitis
摘要
疾病的诊断均从问病史开始，体检、生物化学指标的检测、影像诊断、组织学检查等。体重指数和腰臀比例可作为NAFLD发生的有效预测指标，血糖、血脂常规检查也有助于诊断，但有20％左右的NAFLD患者在确诊时，体重、血脂、血糖均在正常范围。
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2008年第11期811-812,共2页
Chinese Journal of Hepatology
关键词
脂肪肝
诊断
非酒性脂肪性肝炎
Fatty liver
Diagosis
Nonalcoholic steatohepatitis
参考文献18
-
1Kunde SS, Lazenby AJ, Clements RH, et al. Spectum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women. Hepatology, 2005, 42: 650-656.
-
2Bonnefont-Rousselot D, Ratziu V, Giral P, et al. Blood oxidative stress markers are unreliable markers of hepatic steatosis. Aliment Pharmacol Ther, 2006, 23: 91-98.
-
3Solga SF, Alkhuraishe A, Cope K, et al. Breath biomarkers and non- alcoholic fatty liver disease: preliminary observations. Biomarkers, 2006, 11: 174-183.
-
4Wieckowska A, McCulloug A J, Feldstein AE. Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: Present and future. Hepatology, 2007, 46: 582-589.
-
5Abiru S, Migita K, Maeda Y, et al. Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis. Liver Int, 2006, 26: 39-45.
-
6Haukeland JW, Damas JK, Konopski Z, et al. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2. J Hepatol, 2006, 44:1167-1174.
-
7Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science, 2005, 307: 426-430.
-
8Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 2005, 436: 356-362.
-
9Gulsen M, Yesilova Z, Bagci S, et al. Elevated plasma homocysteine concentrations as a predictor of steatohepatitis in patients with non-alcoholic fatty liver disease, J Gastroenterol Hepatol, 2005, 20: 1448-1455.
-
10Yesilova Z, Ozata M, Oktenli C, et al. Increased acylation stimulating protein concentrations in nonalcoholic fatty liver disease are associated with insulin resistance. Am J Gastroenterol, 2005, 100: 842-849.
-
1Jacob George,马雄（译）,叶丽静（译）.非酒精性脂肪性肝炎：病理机制与治疗新概念[J].肝脏,2008,13(1):56-57. 被引量：1
-
2蔡卫民.内源性大麻素受体与非酒精性脂肪性肝炎[J].临床肝胆病杂志,2010,26(2):149-152. 被引量：1
-
3秦泗河.控制腰臀比例防心血管病[J].医药与保健,2008(4):53-53. 被引量：1
-
4中国人的身材比例最健康[J].中老年保健,2008(11):7-7.
-
5田义洲.慢性乙型肝炎伴酒精性脂肪性肝炎的临床研究[J].中国中西医结合消化杂志,2006,14(6):392-393.
-
6陈瑜.瘦素受体Gln223Arg基因多态性与多囊卵巢综合征胰岛素抵抗及脂质代谢的关系[J].临床医药实践,2011,20(12):912-914. 被引量：4
-
7加拿大研究称：中国人腰臀比例最健康身材最好[J].医药与保健,2008(9):4-4.
-
8马增香,陈子江,孔祥辉,曲宁,孙梅,赵力新,唐蓉.肥胖与多囊卵巢综合征患者胰岛素抵抗的临床特征与意义(英文)[J].中国临床康复,2003,7(24):3312-3313. 被引量：8
-
9中国人腰臀比例最健康[J].食品与健康,2008(11):7-7.
-
10加拿大研究称中国人腰臀比例最健康[J].中华中医药学刊,2009,27(12):2692-2692.
